● Investor

Foresite Capital

Life sciences investment firm backing breakthrough healthcare and biotechnology companies

Venture CapitalSan Francisco, United StatesSeries F → Series E

Portfolio

3

companies tracked

Rounds · 12mo

3

participated in

Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.

$560M

sum of tracked rounds

Top stage

Series E

by round count

Recent activity

Rounds LatestRounds has tracked from this investor.

Thyme CareNashville
Series E$125MSep 2
Series A$130MFeb 24
Series F$305MJan 8
Series E$145MJan 1

Where they invest

By stage · rounds, 12mo

Series E1
Series A1
Series F1

Frequent co-investors

No repeat co-investors yet.